VIROPIL TABLET is a combination of Dolutegravir, Lamivudine, and Tenofovir which belongs to the group of medicines called Antiretroviral drugs. It is used to treat HIV (human immunodeficiency virus) infection.
HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient, and reach the most advanced stage of HIV infection called Acquired Immunodeficiency Syndrome (AIDS).
It may present with the symptoms of any other infection like fever, throat pain, extreme tiredness, weight loss, muscle pain.
During the course of the treatment your doctor might take regular blood tests to avoid any unwanted side effects.
Avoid consumption of alcohol while taking VIROPIL TABLET as it may cause bone problems. Consult your doctor before taking.
Before taking VIROPIL TABLET, inform your doctor if you have any kidney, liver, or bone problems. Consult your doctor before taking.
VIROPIL TABLET should be used with caution in pregnant and breastfeeding women only if considered necessary by your doctor. Consult your doctor before taking.
Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before taking VIROPIL TABLET.
The most common side effects of taking VIROPIL TABLET are trouble sleeping, diarrhea, pain, tiredness, headache, rash, depression, and fever and cough. Contact your doctor if any of the above side effects worsen.
VIROPIL TABLET helps to control HIV infection where Dolutegravir inhibits an enzyme (HIV integrase) by binding to the active site and interrupts the HIV replication cycle, resulting in the inhibition of viral activity, and Tenofovir and Lamivudine inhibit HIV replication through incorporation into viral DNA by the enzyme HIV reverse transcriptase, resulting in obstruction of viral DNA synthesis.
Take VIROPIL TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop taking VIROPIL TABLET and consult your doctor immediately if you experience any of the following side effects:
Nausea or Vomiting:
Take VIROPIL TABLET with, or just after meals. Stick to simple meals. Avoid eating oily or spicy foods. Get adequate rest. Drink lots of fluids, especially water. Have small sips if you feel sick. Do not take any medicine for nausea or vomiting without asking your doctor.
Headache:
Drink ample amount of water. Get adequate rest. Try to be relaxed and stress free. Ask your doctor before taking any medicine for headache.
Diarrhea:
Drink lots of fluids, such as water or fruit juice to keep yourself hydrated. Do not consume any medicine on your own without consulting your doctor.
Stomach pain:
Try to rest and relax. Eat and drink slowly or try to have smaller meals more frequently. Keep a heat pad on your stomach. If the symptom does not improve, contact your doctor.
VIROPIL TABLET should be used in pregnant women only if considered necessary by your doctor. Consult your doctor for advice.
VIROPIL TABLET should be used in breastfeeding women only if considered necessary by your doctor. Consult your doctor for advice.
Do not drive or use any machines if you feel dizzy after taking VIROPIL TABLET.
Avoid consumption of alcohol while taking VIROPIL TABLET as it may cause bone problems.
VIROPIL TABLET should be used with caution in patients with kidney problems or receive kidney dialysis treatment. Consult your doctor before taking it.
VIROPIL TABLET should be used with caution in patients with liver problems including hepatitis B infection. Consult your doctor before taking it.
Do not take VIROPIL TABLET if you are allergic to Dolutegravir, Lamivudine, Tenofovir or any of the other ingredients of this medicine.
Before taking VIROPIL TABLET, inform your doctor if you:
Use in pediatrics:
Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before taking VIROPIL TABLET.
A. Drug - Drug interactions:
Before taking VIROPIL TABLET, inform your doctor if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally took too much of VIROPIL TABLET, contact your doctor immediately or visit the nearby hospital.
Drug | : | Dolutegravir, Lamivudine, Tenofovir |
Pharmacological Category | : | Integrase inhibitor, Nucleoside analogue reverse transcriptase inhibitor, Nucleotide reverse transcriptase inhibitor |
Therapeutic Indication | : | HIV infection |
Dosage Forms | : | Tablet |
Q: Does VIROPIL TABLET cure HIV infection?
A: VIROPIL TABLET does not completely cure HIV infection. While taking this medicine, you may still develop infections or other diseases associated with HIV infection. Consult your doctor for advice.
Q: Is VIROPIL TABLET safe in pregnancy?
A: Before taking VIROPIL TABLET, inform your doctor if you are pregnant, think you may be pregnant or are planning to get pregnant because it may harm your unborn baby. Consult your doctor before taking VIROPIL TABLET.
Q: Can VIROPIL TABLET be used on children?
A: Your doctor will prescribe the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before taking VIROPIL TABLET.
Q: What if I miss a dose of VIROPIL TABLET?
A: If you miss a dose of VIROPIL TABLET, take it as soon as you remember. However, omit the missed dose if it is almost time for the next dose. Do not take VIROPIL TABLET twice to make up for a forgotten dose.
Q: Can I stop taking VIROPIL TABLET?
A: Do not stop taking VIROPIL TABLET without consulting your doctor. If you have any more doubts regarding the use of VIROPIL TABLET, ask your doctor.
1. KD. Tripathi. Antiviral drugs. Essentials of Medical Pharmacology. Seventh edition. 2013. Page – 808.
2. PubChem Compound Summary for CID 54726191, Dolutegravir. National Center for Biotechnology Information. June 2022. [Accessed on 2nd June 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Dolutegravir#section=Mechanism-of-Action
3. Katherine Taylor, Kristina Fritz; Mayur Parmar. Lamivudine. StatPearls [Internet]. StatPearls Publishing. May 2022. [Accessed on 11th June 2022] https://www.ncbi.nlm.nih.gov/books/NBK559252/#article-24014.s3
4. Laurus Labs Limited. U.S. Food & Drug Administration. [Revised in January 2021] [Accessed on 11th June 2022] https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/210787PI.pdf
5. Mylan Laboratories Limited. Dolutegravir + Lamivudine + Tenofovir. [Revised in July 2019] [Accessed on 11th June 2022] https://extranet.who.int/pqweb/sites/default/files/HA688part3v1.pdf
6. World Health Organization. HIV/AIDS. [Revised in November 2021] [Accessed on 11th June 2022] https://www.who.int/news-room/fact-sheets/detail/hiv-aids
Written By Dr. Janet.C, Pharm.D
Last updated on 09 Jan 2023 | 11:36 PM(IST)
Additional Discount on this product
Please get a call back from our expert
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.